Philip Morris International reported strong Q2 2026 results, exceeding analyst expectations for both earnings and revenue, primarily driven by robust growth in its smoke-free product portfolio. While the company raised its reported EPS forecast, it lowered its adjusted EPS outlook, indicating a strategic shift towards increased investment in smoke-free products despite short-term earnings adjustments.
Philip Morris International's Q2 2026 earnings beat expectations, with revenue up 10.4% and adjusted EPS increasing to $2.20. This strong performance was largely attributed to the continued success of its smoke-free products, which saw a 7.5% increase in shipments and now account for 42% of total revenue. The company's strategy to prioritize smoke-free growth, including IQOS, ZYN, and VEEV, is clearly paying off, as it expects this segment to largely offset declines in traditional cigarette volumes. While the company raised its reported EPS forecast, it lowered its adjusted EPS outlook due to increased investment in ZYN, suggesting a long-term strategic play over immediate profit maximization. This indicates a positive long-term outlook for PM as it transitions away from combustibles, but traders should be aware of potential short-term volatility due to investment-related earnings adjustments.